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Abstract
The rise of antimicrobial resistance
(AMR) is a severe global health problem.
Tackling this problem requires the prudent
prescribing of antimicrobials. This is pro-
moted through Antimicrobial Stewardship
Programs (ASPs). In this position paper we
describe i) how a socio-technical multidis-
ciplinary approach (based on the CeHRes
Roadmap) can be applied in the develop-
ment and implementation of Antimicrobial
Stewardship technologies and ii) how this
approach can be of value to support
Antimicrobial Stewardship in practice. The
CeHRes Roadmap entails five different
phases to explore and test how an eHealth
technology can be tailored to the target
group and successfully implemented in
practice: i) contextual inquiry, ii) value
specification, iii) design, iv) operationaliza-
tion, v) evaluation. In this position paper we
describe the lessons learned from research
and practice to guide future developments
of technology based ASP interventions.
Since AMR is a huge wicked problem on a
global level, it requires innovative methods
and models to empower general public and
professionals to be proactive rather than
reactive in a digitalized world. We highlight
how to combat the dangerous rise of antimi-
crobial resistance in the future.
Introduction
The rise of antimicrobial resistance
(AMR) is a severe problem,1,2 a problem that
requires a sustainable program and incen-
tives to implement safe care in practice. Such
programs are launched as Antimicrobial
Stewardship Programs (ASPs). These pro-
grams aim to monitor infections, implement
safe work strategies, prevent the misuse of
antimicrobials and educate healthcare work-
ers. Although they are promising, they do not
meet their users’ needs and work practices.
Due to many factors, such as a lack of incen-
tives, bad hygiene behaviors, unworkable
regulations, lack of knowledge, and misuse
of antimicrobials, our healthcare system
becomes a breeding ground for antimicrobial
resistance.2 The mere fact that, in the USA
alone over two million people become
infected with multidrug resistant organisms
each year, resulting in 23.000 deaths annual-
ly, and that costs of antimicrobial resistance
are estimated at $20 billion a year (USA),
stresses the necessity to take action.3,4
Antimicrobial resistance is a huge
wicked problem on a global level,5 with no
single solution that could by itself solve the
problem, requiring a so called theragnostic
model based on infection prevention, antibi-
otic and diagnostic stewardship programs.6
This multidisciplinary stewardship
approach requires intensive collaboration
among stakeholders.5,7 The current state-of-
the-art is to not only combat superbugs with
the development of new drugs, but also to
find behavioral solutions in social sciences
to create optimal conditions for the steward-
ship programs. The Centers for Disease
Control and Prevention also stated that
stewardship programs require a coordinated
multidisciplinary approach and the continu-
ous tracking of prescribing behaviors and
resistance patterns, as well as information
and education strategies to support health-
care workers (HCWs).3 This is where tech-
nology based behavioral solutions will help.
With the introduction of technology in
stewardship programs infection prevention,
antibiotic prescribing and diagnostic inter-
ventions can be personalized to the needs of
patients and healthcare workers.6
In this position paper we describe sever-
al eHealth technologies that we developed
to support infection prevention and/or ASP.
The aim of this paper is to look back on and
provide an overview of our years of experi-
ence with a research-based approach of
developing user-centered eHealth technolo-
gy (following the CeHRes Roadmap) in the
field of ASPs, and to demonstrate why this
approach has value for technologies that
support ASPs. It is not within the scope of
this paper to present measurement data of
the clinical applicability, impact or effec-
tiveness of the technologies. The CeHRes
Roadmap offers a guideline that is used to
develop ASPs that fit its users and its con-
text. In describing how it can be applied to
the development of technology to support
ASPs, we hope to offer guidance to eHealth
technology developers so that such tech-
nologies actually work, help and are imple-
mentable. To do so, we describe i) how a
socio-technical multidisciplinary approach
(based on the CeHRes Roadmap) can be
applied in the development and implemen-
tation of Antimicrobial Stewardship tech-
nologies and ii) how this approach can be of
value to support Antimicrobial Stewardship
in practice. We describe the lessons learned
from research and practice, to guide future
developments of tech-based ASP technolo-
gies. In doing so, we elaborate on the report
by the Centers for Disease Control and
Prevention, which describes what interven-
tions should be implemented in an ASP.3 We
complement this knowledge with insight in
how to realize such interventions, through
technology. 
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The CeHRes Roadmap, 
a multidisciplinary development
approach 
The CeHRes Roadmap was developed
at the Centre for eHealth and Wellbeing
Research of the University of Twente and
introduced in the development of technolo-
gies for infection prevention and control in
several projects (www.eursafety.eu; mrsa-
net.nl).8 The Roadmap prioritizes the
human standard in the development of tech-
nologies for the improvement of healthcare,
incorporating user-centered design princi-
ples, persuasive technology, and a stake-
holder value development approach (busi-
ness modeling). The integration of a user-
centered design approach with a stakehold-
er-driven collaboration procedure during
development enables a sustainable imple-
mentation of technologies in healthcare. In
our view, the development of such tech-
nologies is more than creating a vehicle or
tool to support people. It is a process of co-
creation with end-users and other stake-
holders to guarantee a fit between technolo-
gy, users, and context (way of living and
working). This co-creation process is cou-
pled with continuous and iterative cycles of
evaluation (formative evaluation) to gain
insight in whether a technology can con-
tribute to improving healthcare and what
barriers hinder its implementation.
Therefore, implementation is not a post
design step, but is interwoven with the
development of a technology. As such,
eHealth development is not an ad hoc activ-
ity, but a structural approach to set the con-
ditions for personalized healthcare using
technology. 
The Roadmap entails five different
phases to explore and test how eHealth
technology can be perfectly personalized
and tailored to the target group and success-
fully implemented in practice (Figure 1)
Contextual inquiry 
The objective of the contextual inquiry
phase is to identify the weak and strong
points of the current situation, for example
current Stewardship approaches to reduce
AMR, to inquire the needs of stakeholders
to improve health, how technology can be
used to deal with the problems and needs,
and to identify regulations and conditions
that should be taken into account (i.e., leg-
islation, regulations, policy) to implement
an eHealth technology.9
Value specification 
The value specification phase builds on
the results of the contextual inquiry. The
identified key-stakeholders determine the
added values (economical, medical, organi-
zational etc.) that they want to achieve by
means of a technical solution for the
improvements in healthcare, such as a
reduction of AMR. These values can be
ranked in order to create a feasible technol-
ogy and to set conditions for implementa-
tion (see also www.eHealthWiki.org).10 The
values will be translated by the project man-
agement team (Research & Development)
into system, content and service require-
ments in a value map. 
Design
Within this phase of the Roadmap, the
design (the look-and-feel) of the technology
is developed. In close cooperation with end-
users (e.g., doctors, nurses, patients) several
design-prototypes (from paper-based until
fully functioning technology) can be devel-
oped and tested using scenarios that repre-
sent the context: the use of an AMR tech-
nology in healthcare practice. For the
design of such prototypes, usability princi-
ples and persuasive design models (e.g., the
Persuasive Systems Design Model) can be
used to ensure a fit between technology, its
use context and its users.9,11,12
Operationalization
This phase entails activities to introduce
a technology in healthcare. An implementa-
tion and a business model (e.g., timing,
activities, actors, budget) is developed
together with an evaluation plan to examine
whether the goals, or values are realized.7
Evaluation 
To examine whether an eHealth tech-
nology works and helps, ongoing evaluation
rounds (i.e., formative evaluation) are con-
ducted throughout the whole developmental
phase. Additionally, a final evaluation
round (i.e., summative evaluation) is per-
formed after implementation to measure the
effects on behavior change, attitudes and
the impact on the goals to be realized.
The CeHRes Roadmap is a guide that
can be used integral to develop and imple-
ment technologies, as a guide to assess the
developmental process or to guide a (par-
tial) redesign process.
Development of technology for
antimicrobial stewardship pro-
grams via the CeHRes Roadmap
In this paper, we describe how the
CeHRes Roadmap was used to develop sev-
eral technologies to share information and
to communicate with HCWs, about how to
prevent infections and how to avoid antimi-
crobial resistance. The CeHRes Roadmap
has a good fit with complex problems like
AMR and the integrated stewardship model
because of its’ multidisciplinary and socio
technical based development approach.6 We
elaborate per ASP technology on a specific
phase of the Roadmap, most suitable to deal
with wicked problems and to focus on stew-
ardship supporting HCWs with technolo-
gies relevant for AMR. The described tech-
nologies are or will all be offered through
and bundled on a website called Infection
Manager (beta version available on
www.infectionmanager.com), which serves
as a platform for communication and infor-
mation sharing to support Integrated AMR
Stewardship. In this paper we describe i) a
technology to support decision making
about antimicrobials (focusing on
Contextual Inquiry), ii) a maturity model to
guide the implementation of ASP technolo-
gies (Value specification &
Operationalization), iii) a technology to
support nurses in antimicrobial administra-
tion (Design to fit the use context), and d) a
technology to register infections for nursing
homes (Persuasive design).
Technology to support decision
making about antimicrobials 
(contextual inquiry)
Background
Decision making in an ASP is a com-
plex matter. Many factors influence a deci-
sion on how to diagnose and decide what
treatment a patient needs. To support physi-
cians in making decisions about the pre-
scribing of antimicrobials, Clinical
Decision Support Systems (CDSSs) are
proposed and often implemented.13
However, their success largely differs,
mainly due to low use and low adherence
rates. To increase the chances of success,
CDSSs should fit its users’ needs and
expectations, but also their work processes.
Activities
We conducted a Contextual Inquiry to
identify why and how a clinical decision
system can support the prescribing of
antimicrobials. A scoping review of the lit-
erature on existing CDSSs provided insight
in their current development, design and
implementation. It revealed a lack of
involvement of potential end-users during
the development, but also a lack of attention
for the design process of CDSSs (most pub-
lications do not report on how a CDSS was
developed). In general, existing CDSSs
mainly have a clinical focus, but lack atten-
tion for stewardship and how to support
decisions in practice. Insights from the
scoping review were used to develop, test,










[page 38]                                                      [Infectious Disease Reports 2017; 9:6829]
and evaluate scenario-based prototypes
with end users. Observing physicians while
they interact with these prototypes provided
insight into the existing work processes
(e.g., current information sources), prob-
lems that end-users experience (e.g., indis-
tinctness about duration of an AB therapy)
and users’ preferences and needs regarding
the look and feel of the technology.
Lessons learned
Early involvement of stakeholders and
end-users is necessary to develop user
friendly ASP technologies. Stakeholders,
like experts in the field of infections and in
other medical specialties, are needed to con-
tinuously keep an eye on the fit between
technology and clinical practice, and to set
conditions for implementation.
Scenario-based prototype evaluations
enable potential end-users to visualize and
verbalize their work processes and prob-
lems they encounter, and to think outside
their comfort zone, to discuss opportunities
of technology based ASP.
Scenario-based prototype evaluations
(and cross-referencing its findings among
other stakeholders) provide valuable infor-
mation to harmonize and translate medical-
ly focused protocols and guidelines into
practice based instructions.
Involvement of end-users provides clear
insight into improvements for the complex
work environment that healthcare is. For
example, currently most eHealth technolo-
gy to support ASPs is directional, restrictive
and less integrated with practice. Medical
autonomy (which is a prerequisite for being
able to deal with complex and ever chang-
ing circumstances) of e.g., physicians is
sometimes neglected in ASP. End-users
clearly indicated a need for a technology to
respect and keep account with their medical
autonomy, and to give room for deliberation
(i.e., diagnostics as triage for decision mak-
ing).
Maturity model to implement
antimicrobial stewardship 
technologies (value specification 
and operationalization)
Background
Infection prevention and control should
be considered as an integrated healthcare
approach.6 To determine what ASP inter-
ventions should be developed and to facili-
tate implementation, involvement of stake-
holders is crucial. A maturity model can
help to assess the activities already done
and to guide the development of interven-
tions, in cooperation with stakeholders such
as medical professionals, infection experts,
and (local) managers.
Activities
Business modeling activities were per-
formed to identify the key stakeholders and
to determine the values that have to be real-
ized with ASPs in practice.14
Multidisciplinary focus groups were con-
ducted to decide what ASP technologies
should be developed, to define their require-
ments, and to identify necessary resources
and skills, from planning until operational-
ization of an ASP.15
Lessons learned
ASP interventions, supported by tech-
nology, can be bundled in a toolkit. Such
ASP toolkit offers a set of technologies that
are intended to support an integrated ASP
approach;16
i. Information app to support antimicro-
bial prescribing (aimed at physicians)
ii. Interactive antimicrobial prescription
decision support app
iii. Information app to support antimicro-
bial administration (in the Netherlands
aimed at nurses)
iv. Information app to transfer patient care
v. Tool to facilitate audits by the ASP-
team
vi. Alerts/notifications
vii. Education via E-Learning
Our maturity assessment checklist with
questions regarding the status nascendi of
local technologies can be used to decide the
maturity of the ASP initiatives (e.g., done,
planned).
The maturity model that we developed
guides the development of these technolo-
gies considering the aims, resources and
capabilities of a local organization and
(inter)national regulations for ASP. It pres-
ents the necessary information in manage-
able and relevant fragments to A-teams that
are in the process of implementing ASP.
That also makes it different from the few
existing ASP guidelines or toolkits that
exist.14
In Figure 2 an overview of the maturity
model for implementing ASP is given. Each
button will have submenus with further
implementation information. 




Optimal use of antimicrobials relies on
careful prescription and administration.
Often, the manuals and protocols that
describe these complex activities are
expert-driven, difficult to understand, inac-
curate, or not in line with novel insights.17
Nurses can play a key role in adminis-
tration and monitoring of antimicrobials.
They can inform physicians on the (actual)
use and effects of antimicrobials on their
patients, based on their daily care activi-
ties.17 This informative role is implicit in
medical protocols. Yet, the cooperation
between nurses and physicians in streamlin-
ing antimicrobial care for patients is crucial
for successful ASPs.18
Activities
The contextual inquiry that was carried
out in the participating local teaching hospi-
tal indicated that nurses need information
that supports them in their preparation,
administration and monitoring tasks, and
that assists them to observe possible risks or
adverse events associated with antimicro-
bial therapy.17 User-centered design princi-
ples with a focus on nurses’ daily tasks were
used to design prototypes of the Antibiotic
Information app with nurses, doctors,
microbiologist and pharmacists. To change
the protocols into more usable and task-ori-
ented information sources, card sorting was
done. This method helps to create intuitive
information structure for online information
sources.19 Nurses sorted cards with small
chunks of information (e.g., parts of proto-
cols, reference documents) in (what they
regard as) logical groups. In addition, they
                             Review
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named each group while thinking aloud. On
the resulting sorts, a cluster analysis was
performed to show how different informa-
tion parts are related, according to the nurs-
es, based on their experience. The results
show that the app should present informa-
tion in a task-oriented way, including prac-
tical instructions (e.g., on dose, preparation,
administration and monitoring). In addition,
background information (e.g., about the dis-
ease that requires antimicrobial treatment or
specific characteristics of the antimicro-
bials) should be included (Figure 3).
Lessons learned
To support the tasks of nurses, insight in
information use is required.
For technologies to be optimally sup-
portive, explicit elicitation of and decisions
on functional requirements (i.e., what the
technology should be able to do) and design
requirements (i.e., what interfaces should
look like, how information should be struc-
tured to support tasks) is needed.
Information should primarily be task
oriented, but additional (in-depth) explana-
tions and resources should be accessible as
well, to reflect medical standards.
Information availability is a prerequisite
for active nurse involvement in ASP, but
eLearning is needed to stimulate novel
practices. 
Technology to register infections in
nursing homes (design)
Background
Once a year, nursing homes that are part
of the (Dutch) iPrevent network register all
their clients in a prevalence measurement of
nursing home-associated infections and
related risk factors (e.g., presence of
catheters, antimicrobial use). This task is
performed by elderly care physicians, who
thus have to register numerous clients with-
in a short period. The previous (paper-
based) tool that was used to do so was time
consuming, laborious and prone to interpre-
tation errors.11 To deal with these issues, a
web-based registration and monitoring app
for nursing home-associated infections (the
Prevalence app) was developed.
To increase adherence it is important
that technologies to support ASP, support its
end-users in performing their tasks and
should motivate them in doing so.
Persuasive technology offers such sup-
port,12 to improve adherence with certain
rules of conduct. Persuasive infection man-
agement is not focused on punishing bad
compliance, as this has a demotivating
effect, but on a positive, rewarding
approach to behavioral change. 
Activities
Scenario-based prototypes were evalu-
ated by elderly care physicians (the intend-
ed end-users). For scenario-based user test-
ing, a low-fidelity prototype of the
Prevalence app was developed, incorporat-
ing elements of persuasive design. For
example: 
Primary Task Support was provided to
simplify the tasks (e.g., reduction to shorten
questions) and to make it less time consum-
ing (e.g., tunnelling to omit irrelevant ques-
tions). 
Dialogue Support was incorporated to
avoid errors (e.g., suggestion to avoid typ-
ing errors, Figure 4) and to make sure all
relevant information is included (e.g.,
reminders to add laboratory test results as
soon as they are available). 
System Credibility Support was embed-
ded to ensure its face validity (e.g., by clear-
ly displaying the logo of the INTERREG
IVa EurSafety Health-net project that it was
developed in) and its reliability (e.g., by
embedding the app in a larger website
which provided additional information
about the project and the experts who were
involved in its development).
Social Support was used to allow nurs-
ing homes to reflect on their own infection
rates (i.e., social Comparison to compare
the own data that with a benchmark of the
other participating nursing homes). 
Lessons learned
Persuasive technology matters.
Preliminary evaluations showed that end-
users performed (fictional, but real-life)
tasks faster and with less mistakes than with
the prior web-based system.20
Preliminary evaluations indicated that
the perceived persuasiveness of the
Prevalence app was higher than of the prior
system.20
End-users expressed appreciation for
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the improved integration of working with
the Prevalence app in their work processes.
It enabled them to pause and continue regis-
tration at a later point in time, without los-
ing data (as opposed to the prior system).
Conclusions 
In this position paper we have high-
lighted how technology can be used to con-
tribute to fight antimicrobial resistance
(AMR). AMR is a huge wicked problem on
a global level, requiring innovative methods
and models on a local level to empower our
public and professionals to be proactive
rather than reactive in a digitalized world.
Technology supports the development of an
integrated ASP, crossing borders between
healthcare and public health.5
The CeHRes Roadmap provides the
methodology to guide the ASP toolkit
development process, providing methods
for involving end-users (to create and test
prototypes) and stakeholders (to define the
added values and conditions for the imple-
mentation). The digitalization of informa-
tion and the options for mobile technology
facilitate an integrated and technology
based Antimicrobial Stewardship Model.6
Furthermore, ubiquitous digital networks
offer facilities for continuous web-based
education of the public, healthcare
providers and infection prevention experts,
making new knowledge easily available
through eLearning modules.10
The methods and lessons learned that
are described in this paper are primarily
applicable to and relevant for Antimicrobial
Stewardship efforts. This is a highly com-
plex field, that deals with highly complex
‘wicked’ problems. However, we are con-
vinced that this paper may also be of value
for other ‘wicked’ problems, such as the
field of zoonoses.5
Future work
The Centers for Disease Control and
Prevention highlighted the key elements for
ASP,3 we think technology can support the
realization of the key elements by creating
an infrastructure for infection prevention
interventions and by continuous surveil-
lance of antimicrobial use. 
Automated surveillance systems have
already been shown to be sensitive, specific
and efficient to prevent the spread of Highly
Resistant Micro Organisms (HRMO) and to
reduce healthcare-associated infections.21-23
However, current surveillance methods lack
a systematic approach to detect changes or
patterns in events that require acute inter-
ventions. Nor is surveillance currently used
to predict antimicrobial resistance problems
and upcoming outbreaks of diseases due to
the lack of advanced analytics. Predictive
analytics, using technologies to learn from
historical data to make predictions about
future health, are needed to enrich the cur-
rent surveillance systems. Today an exten-
sive growth in the amount of data in health-
care is digitally generated, collected, and
stored via mobile and wearable technolo-
gies. These technologies provide opportuni-
ties to develop predictive, automated deci-
sion support systems, for public health and
medical care settings. Using advanced algo-
rithms in real-time modus and facilitating
risk communication for proactive decision
making in the prevention of HRMO out-
breaks. We need to ensure there is a human
standard in these developments, so that such
information is not only available but also
accessible and usable for health care work-
                             Review
Figure 3. The Antibiotic Information app to support nurses in Antimicrobial Stewardship
Programs.17
Figure 4. Example of suggestion in a low-
fidelity prototype.11










                                   [Infectious Disease Reports 2017; 9:6829]                                                    [page 41]
ers, patients, citizens, and other stakehold-
ers during their daily life or work. In current
AMR projects (i.e., INTERREG Va Health-
i-care, eZoon ZonMw) we use the ASP
toolkit to develop an eLearning environ-
ment and a web-based early warning deci-
sion support system to educate profession-
als and public, to reduce AMR.
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